Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis

Table 4 Efficacy of chemotherapy and pathological findings

	DCF (%), N = 37	bDCF (%), N = 22	p value
Clinical response
CR/PR/SD/PD	2/21/13/1	0/19/3/0
Response rate			0.047
CR + PR	23 (62.2)	19 (86.4)
Histological therapeutic effect^a			0.312
Grade 0/1a/1b/2/3	3/16/6/7/5	1/4/6/6/5
Grade of differentiation^a			0.593
Well differentiated	6	5
Moderately differentiated	17	7
Poorly differentiated	8	4
Not determined	6	6
Lymphatic vessel invasion^a			0.358
ly0/ly1/ly2/ly3	16/16/2/3	13/7/2/0
Blood vessel invasion^a			0.117
v0/v1/v2/v3	16/20/1/0	12/7/3/0
pT stage^b			0.542
T0/Tis/T1/T2/T3/T4a	5/0/6/8/17/1	5/1/5/3/8/0
pN stage^b			0.219
N0/N1/N2/N3	17/16/3/1	11/8/0/3
pStage^b			0.606
0/IA/IB/IIA/IIB/IIIA/IIIB/IIIC/IV	5/5/3/5/4/11/1/2/1	4/2/2/3/5/2/0/2/2

CR complete response, PD progression disease, PR partial response, SD stable disease
^aAccording to the Japanese Classification of Esophageal Cancer, 11th edition
^bAccording to the UICC classification, 7th edition

ISSN: 1477-7819